Steven A. Lisi - 04 Nov 2025 Form 4 Insider Report for Beyond Air, Inc. (XAIR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Nov 2025, 21:46:52 UTC
Prior SEC filing
06 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Steven A. Lisi

Key filing fact

Steven A. Lisi filed Form 4 for Beyond Air, Inc. (XAIR) on 06 Nov 2025.

Key facts

  • This page summarizes Steven A. Lisi's Form 4 filing for Beyond Air, Inc. (XAIR).
  • 16 reported transactions and 16 derivative rows are listed below.
  • Accepted by SEC: 06 Nov 2025, 21:46.

Change

  • Previous filing in this sequence was filed on 06 Nov 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001702628 Primary reporting owner

Lisi Steven A.

Relationship
CEO and Chairman of the Board, Director
Address
C/O BEYOND AIR, INC., 900 STEWART AVENUE, SUITE 301, GARDEN CITY
Signature
/s/ Steven A. Lisi
Signature date
06 Nov 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XAIR transaction Derivative

Stock Options (Right to buy)

Disposed to Issuer

Transaction value
Shares
-47,500
Change %
-100%
Price
Shares after
0
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
47,500
Exercise price
$10.80
Footnotes
F1, F2
XAIR transaction Derivative

Stock Options (Right to buy)

Award

Transaction value
Shares
+47,500
Change %
Price
Shares after
47,500
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
47,500
Exercise price
$1.95
Footnotes
F1, F2
XAIR transaction Derivative

Stock Options (Right to buy)

Disposed to Issuer

Transaction value
Shares
-40,000
Change %
-100%
Price
Shares after
0
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
40,000
Exercise price
$10.80
Footnotes
F1, F2
XAIR transaction Derivative

Stock Options (Right to buy)

Award

Transaction value
Shares
+40,000
Change %
Price
Shares after
40,000
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
40,000
Exercise price
$1.95
Footnotes
F1, F2
XAIR transaction Derivative

Stock Options (Right to buy)

Disposed to Issuer

Transaction value
Shares
-14,000
Change %
-100%
Price
Shares after
0
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
14,000
Exercise price
$10.80
Footnotes
F1, F2
XAIR transaction Derivative

Stock Options (Right to buy)

Award

Transaction value
Shares
+14,000
Change %
Price
Shares after
14,000
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
14,000
Exercise price
$1.95
Footnotes
F1, F2
XAIR transaction Derivative

Stock Options (Right to buy)

Disposed to Issuer

Transaction value
Shares
-10,000
Change %
-100%
Price
Shares after
0
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$10.80
Footnotes
F1, F2
XAIR transaction Derivative

Stock Options (Right to buy)

Award

Transaction value
Shares
+10,000
Change %
Price
Shares after
10,000
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$1.95
Footnotes
F1, F2
XAIR transaction Derivative

Stock Options (Right to buy)

Disposed to Issuer

Transaction value
Shares
-3,500
Change %
-100%
Price
Shares after
0
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,500
Exercise price
$10.80
Footnotes
F1, F2
XAIR transaction Derivative

Stock Options (Right to buy)

Award

Transaction value
Shares
+3,500
Change %
Price
Shares after
3,500
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,500
Exercise price
$1.95
Footnotes
F1, F2
XAIR transaction Derivative

Stock Options (Right to buy)

Disposed to Issuer

Transaction value
Shares
-12,500
Change %
-100%
Price
Shares after
0
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,500
Exercise price
$10.80
Footnotes
F1, F2
XAIR transaction Derivative

Stock Options (Right to buy)

Award

Transaction value
Shares
+12,500
Change %
Price
Shares after
12,500
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,500
Exercise price
$1.95
Footnotes
F1, F2
XAIR transaction Derivative

Stock Options (Right to buy)

Disposed to Issuer

Transaction value
Shares
-20,000
Change %
-100%
Price
Shares after
0
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,000
Exercise price
$10.80
Footnotes
F1, F2
XAIR transaction Derivative

Stock Options (Right to buy)

Award

Transaction value
Shares
+20,000
Change %
Price
Shares after
20,000
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,000
Exercise price
$1.95
Footnotes
F1, F2
XAIR transaction Derivative

Stock Options (Right to buy)

Disposed to Issuer

Transaction value
Shares
-47,500
Change %
-100%
Price
Shares after
0
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
47,500
Exercise price
$5.89
Footnotes
F1, F2
XAIR transaction Derivative

Stock Options (Right to buy)

Award

Transaction value
Shares
+47,500
Change %
Price
Shares after
47,500
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
47,500
Exercise price
$1.95
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged.

Footnote F2

This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .